Watch Ticker

Arvinas, Inc

Go to Arvinas, Inc Website

$7.35

-0.26 (-3.42%)

Live

Previous Close

$7.61

Day Range

$0 - $0

Previous Day Range

$7.41 - $7.83

Market Cap

$549.6 million USD

Day Vol.

Previous Day Vol.

2.0 million

Currency

USD

Primary Exchange

Nasdaq

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade dis...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress

Arvinas presented preclinical data for its investigational PROTAC BCL6 degrader, ARV-393, showing significant single-agent activity in models of certain lymphoma subtypes and enhanced antitumor activity in combination with small molecule inhibitors in aggressive diffuse large B-cell lymphoma models.

Related tickers: ARVN.

Read Full Article

N/A - Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

Arvinas has submitted a New Drug Application to the FDA for vepdegestrant, a potential treatment for patients with ESR1-mutated ER+/HER2- advanced or metastatic breast cancer. The submission is based on positive results from the VERITAC-2 Phase 3 clinical trial.

Related tickers: ARVN, PFE.

Read Full Article

Trending Tickers

Please sign in to view